In September, the FDA quietly approved a generic form of mifepristone, the first pill of a two-part abortion medication-a surprising move for a regime that lives and breathes on making women's lives worse. Speaking about the decision at the time, White House Press Secretary Karoline Leavitt promised that the move wasn't an endorsement for abortion. They can say whatever they want, but the approval means expanded abortion access, since there are now three companies in the U.S. manufacturing mifepristone.
The attorneys general of more than a dozen states on Thursday sued the Trump administration over the termination of $7 billion in funding intended for affordable solar energy projects across the U.S. The coalition, which also included the District of Columbia and other stakeholders, argued in the lawsuit that the Environmental Protection Agency's cancellation of the Solar for All program violated the law governing federal agencies and the constitutional separation of powers.